Am J Transplant, Volume 20, Suppl 3 Archives - Page 86 of 223 - ATC Abstracts

2020 American Transplant Congress
Geographic Distribution of End-Stage Renal Disease in the US: The First Description of an “ESRD Belt”
R. D. Reed¹, H. Qu¹, P. A. MacLennan¹, M. N. Mustian¹, D. Anderson¹, A. C. Kale¹, B. J. Orandi¹, B. A. Shelton¹, V. Kumar², M. J. Hanaway¹, J. E. Locke¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Medicine, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Previous research has demonstrated that population health is associated with organ supply and transplantation; this is particularly true in the southeastern United States, which…
2020 American Transplant Congress
Is Ischemia Reperfusion Injury Immediately after Heart Transplantation Correlated to Increased Intimal Thickening in the First Year?
J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, K. Nishihara, A. Velleca, L. Czer, F. Esmailian, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Ischemia reperfusion injury (IRI) is not uncommon in heart transplant patients due to high dose inotropes, ischemic time, and technical surgical reasons. Ischemia in…
2020 American Transplant Congress
Child-Turcotte-Pugh Class at Transplantation Predicts Mortality after Heart Transplantation Following Left Ventricular Assist Device Placement
E. Leven¹, A. T. Kurdi², S. Pinney¹, T. Schiano¹, J. Crismale¹
¹Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, ²Gastroenterology, Mayo Clinic, Rochester, MN
*Purpose: The primary aim of this study is to assess whether Child-Turcotte-Pugh (CTP) class is associated with mortality in end-stage heart disease patients undergoing left…
2020 American Transplant Congress
Evaluation of Bronchial Artery Revascularization in Lung Transplantation: A Systematic Review and Meta-Analysis
T. J. O'Malley¹, A. M. Jordan¹, E. J. Maynes¹, A. Saxena¹, K. W. Prochno¹, T. K. Rajab², H. T. Massey¹, R. C. Daly³, V. Tchantchaleishvili¹
¹Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, PA, ²University of Colorado, Aurora, CO, ³Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN
*Purpose: Bronchial artery revascularization (BAR) during lung transplantation has been hypothesized to improve early tracheal healing and delay the onset of bronchiolitis obliterans. We evaluated…
2020 American Transplant Congress
Vascular Complications in Pediatric Intestine Transplant Recipients – Treatment Strategies and Outcomes
A. Amin, Y. Chang, B. Emmanuel, A. Ganoza, G. Bond, A. Khanna, K. Soltys, R. Sindhi, G. Mazariegos
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: To identify vascular complications in pediatric intestine transplant (IT) recipients, evaluate treatment strategies, and review their impact on graft loss and patient mortality.*Methods: Retrospective…
2020 American Transplant Congress
Clinical Performance of a Donor-Derived Cell-Free DNA Assay for Detection of Rejection in Kidney Transplant Recipients
S. Kleiboeker, J. Grantham, K. Mickey, S. Cowden, E. Bixler, R. Sinha, M. Altrich
Viracor Eurofins, Lees Summit, MO
*Purpose: Rejection is a major complication in solid organ transplant recipients and diagnosis often depends on periodic invasive biopsies. Thus there is a need for…
2020 American Transplant Congress
Comparative Proteomics Analysis Identifies L-FABP as a Putative Biomarker of Graft Injury During Liver Transplantation Using the ITRAQ/MRM Approach
M. Chen, Y. Zhang, M. Han, W. Ju, Q. Zhao, Y. Chen, D. Wang, X. He
Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: In liver transplantation, much of factors have a pernicious influence on liver donor quality, such as hepatic steatosis, long term of donor hypotension, cardiac…
2020 American Transplant Congress
Treatment Strategies to Suppress Donor Specific Antibodies: Highlights from a Decade of Research Experience in a Mouse Model of Allo-Sensitization
I. Kim, G. Wu, N. Chai, T. Brennan, A. Klein, S. Jordan
Cedars-Sinai Med Ctr, Los Angeles, CA
*Purpose: Difficulty in desensitization in highly sensitized patients remain problematic in organ transplantation. For over 12 years, our laboratory has been carrying out an HLA…
2020 American Transplant Congress
Deceased Donor Body Temperature is Associated with Delayed Graft Function in Kidney Transplant Recipients
J. Mancinelli¹, N. Mahmud², L. Krumeich¹, M. Harhay³, P. P. Reese⁴, D. Goldberg⁵, P. Abt⁶
¹Department of Surgery, University of Pennsylvania, Philadelphia, PA, ²Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, ³Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, ⁴Renal-Electrolyte and Hypertension Division, Department of Medicine, Center for Clinical Epidemiolog, University of Pennsylvania, Philadelphia, PA, ⁵Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami, Miami, FL, ⁶Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA
*Purpose: Delayed graft function (DGF) among kidney transplant recipients complicates the post-operative course and is associated with graft failure. Intentional cooling of the donor may…
2020 American Transplant Congress
Sirolimus (SRL) versus Everolimus (EVR) versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Anti-Thymocyte Globulin Induction (r-ATG), Tacrolimus (TAC), and Prednisone
H. Tedesco Jr., C. T. Felipe, L. Viana, M. Cristelli, N. Tenório, V. Lima, V. Azevedo, K. Ficher, J. Rezende, R. Demarchi, M. Nakamura, Y. Dreige, G. Ormenesse, J. Taddedo, L. Takara, C. Santos, L. Damasceno, J. Pestana
Nephrology Division, Hospital Do Rim, Sao Paulo, Brazil
*Purpose: The aim of this study is to compare the efficacy and safety of SRL versus EVR versus MPA in kidney transplant recipients*Methods: This is…